Mycovia Pharmaceuticals Revenue, Growth & Competitor Profile

DBA Innocrin Pharmaceuticals Holdings, LLC
DBA MYCOVIA PHARMACEUTICAL, INC.
DBA MYCOVIA PHARMACEUTICALS (NC), INC.
DBA VIAMET PHARMACEUTICALS, INC
DBA VIAMET PHARMACEUTICALS (NC), INC.

Company Profile & Annual Report for Mycovia Pharmaceuticals

Access the complete profile.

Mycovia Pharmaceuticals Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	621 Ambulatory Health Care Services
Address	4721 Emperor Blvd Ste 220 Durham, NC 27703

Note: Revenues for privately held companies are statistical evaluations.


Mycovia Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Mycovia Pharmaceuticals's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Mycovia Pharmaceuticals is classified as operating in the Ambulatory Health Care Services industry, NAICS Code 621.

Mycovia Pharmaceuticals Annual Revenue and Growth Rate

Mycovia Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Mycovia Pharmaceuticals's revenues are gauged from an analysis of company filings.

Mycovia Pharmaceuticals's Income Statement (based on Industry Averages)

Mycovia Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Mycovia Pharmaceuticals is developing and marketing. Mycovia Pharmaceuticals doesn't have any recent trademark applications, indicating Mycovia Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
MY VIVJOA administration of a program for enabling participants to obtain discounts on the cost of prescription or over-the-counter medications; providing online consumer product information for the purpose of selection of pharmaceuticals or over-the-counter; membership services, namely, operation and maintenance of a membership program for discount price pharmaceuticals or over-the-counter; administration of a program for enabling participants to obtain discounts on the cost of prescription or over-the-counter medications in the field of women's health	03/15/2023
MEYKODA Pharmaceutical preparations and substances for the treatment and/or prevention of fungal and parasitic infections; Pharmaceutical preparations and substances for the prevention and/or treatment of mucosal, invasive, and superficial fungal infections, including those caused by candida and dermatophyte species; Pharmaceutical preparations and substances for the prevention and/or treatment of endemic fungal diseases or infections; Pharmaceutical preparations for the treatment and prevention of skin conditions; Pharmaceutical preparations, namely, gels, creams, sprays or other topical preparations treatment of skin conditions; Intravenous pharmaceutical preparations for the treatment and prevention of invasive fungal infections	03/12/2020
FYIENSIA Pharmaceutical preparations and substances for the treatment and/or prevention of fungal and parasitic infections; Pharmaceutical preparations and substances for the prevention and/or treatment of mucosal, invasive, and superficial fungal infections, including those caused by candida and dermatophyte species; Pharmaceutical preparations and substances for the prevention and/or treatment of endemic fungal diseases or infections; Pharmaceutical preparations for the treatment and prevention of skin conditions; Pharmaceutical preparations, namely, gels, creams, sprays or other topical preparations treatment of skin conditions; Intravenous pharmaceutical preparations for the treatment and prevention of invasive fungal infections	03/12/2020

See all trademarks and details in the Full Report.

Market Share of Mycovia Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Mycovia Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
RETINA GROUP INC. DBA RETINA CONSULTANTS	Southlake, TX	100
ROYAL CARE CERTIFIED HOME HEALTH CARE	Brooklyn, NY	92
KAISER FOUNDATION HOSPITALS	Oakland, CA	70
MOLINA HEALTHCARE	Long Beach, CA	57
MAYO CLINIC AMBULANCE	Rochester, MN	34
HAMASPIK CARE	Spring Valley, NY	29
NATIONAL MEDICAL CARE	Waltham, MA	27
HAH HOLDINGS	Chicago, IL	26
PROHEALTH PHYSICIANS P.C.	Farmington, CT	23

Nearby Competitors

These companies are similar in business line and location to Mycovia Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PRIVATE DIAGNOSTIC CLINIC PLLC	Durham, NC	100
EMERGEORTHO PA	Durham, NC	44
AVANCE HEALTH SYSTEM	Durham, NC	28
DOCTORS MAKING HOUSE CALLS	Durham, NC	15
LIVHOME	Durham, NC	13
LINCOLN COMMUNITY HEALTH CENTER	Durham, NC	6

Future Competition: Mycovia Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Mycovia Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)